Adequate glycemic control in people with diabetes decreases the risk of developing both microvascular and macrovascular complications. 1,2 To achieve adequate glycemic control, frequent self-monitoring of blood glucose (SMBG) is often necessary. The American Diabetes Association recommends that individuals with diabetes monitor their blood glucose as frequently as necessary to safely manage their condition, often as many as 4 to 6 times daily. 3 The current standard method for SMBG biochemically measures capillary glucose with a portable meter and requires lancing the skin to obtain blood. Although this method is often numerically and clinically accurate, it has shortcomings. Lancing the skin is often associated with pain, which discourages long-term compliance. Also, glucose meter technology relies on episodic testing and thus requires a motivated individual to remember to test several times a day. There are continuous glucose monitoring devices (CGM) available for continuous estimation of plasma glucose concentration, but these require insertion of a cannula into the skin and thus are still invasive. Clearly, there is a need for alternative device technologies, which ideally should be noninvasive, painless, and easy to use while providing reasonable estimations of plasma glucose concentrations to make informed decisions on diabetes self-management. 4,5 Even when glucose estimates are not perfectly accurate, close estimates can be of clinical value in determining glucose trends that help inform self-management.